CTLA4 and neoplasm: In 1996, Allison and colleagues showed that antibodies directed against CTLA‐4 lead to rejection of existing tumours in a mouse model,41 and that this response remains in immunological memory on re‐challenge, suggesting a role for CTLA‐4 in tumour immune evasion.